Ingenol mebutate in the treatment of actinic keratoses: clearance rate and adverse effects

Ingenol mebutate in the treatment of actinic keratoses: clearance rate and adverse effects

Abstract: Background: Actinic keratoses are benign intraepithelial skin neoplasms that develop in photoexposed areas and can progress to invasive carcinoma. They are seen frequently in dermatological practice, occurring in 5.1% of consultations. Ingenol mebutate (IM) was recently approved in Brazil...

Full description

Bibliographic Details
Main Authors: Maria Isabel Ramos Saraiva, Larissa Karine Leite Portocarrero, Marcella Amaral Horta Barbosa Vieira, Bethania Cabral Cavalli Swiczar, Andrezza Telles Westin
Format: Article
Language:English
Published: Sociedade Brasileira de Dermatologia 2018-08-01
Series:Anais Brasileiros de Dermatologia
Subjects:
Keratosis, actinic
Skin neoplasms
Therapeutics
Treatment outcome
Online Access:http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0365-05962018000400006&tlng=en

Similar Items

Similar Items